Brief: Mimedx Announces Fourth Quarter And Full Year 2022 Operating And Financial Results
Feb 28 (Reuters) - Mimedx Group Inc MDXG.O :
* MIMEDX ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
OPERATING AND
FINANCIAL RESULTS
* QTRLY NET SALES OF $74.4 MILLION
* QTRLY NET LOSS PER COMMON SHARE - DILUTED $0.02
* Q4 REVENUE VIEW $74.5 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbgbmkD
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million